Medication Management

Expanding scopes of practice for NPs and pharmacists working independently outside of teams is adding to the strain on doctors.

Our summer plans were gradually cancelled due to the inexorable progress of fires in the South Slave region. Although the town issued an evacuation notice, the first phase in advising residents to prepare in case of a need to evacuate, it never really felt like an evacuation would actually happen. Could it?

Study provides insight on the value of a new orally-administered, selective P2X3 receptor antagonist antitussive that is under review by Health Canada.

The leading decongestant used by millions of Americans looking for relief from a stuffy nose is likely no better than a dummy pill, according to government experts who reviewed the latest research on the long-questioned drug ingredient.

An essay in the New York Times from pediatrician Dr. Aaron E. Carroll has kicked off discussion as to why patients are reluctant to engage with proven pharmacological treatments—especially where certain stigmatized conditions like depression or obesity are concerned.

Prosecutors started an investigation in 2015 after undercover trash inspectors found pharmaceutical drugs, and syringes filled with human blood and even body parts removed during surgery inside bins handled by municipal waste haulers.

Calgary general practitioner Dr. Bruce Hoffman, who practises traditional and functional medicine, also double-billed for some of the same services—charging both the patient and the province, according to the College of Physicians and Surgeons of Alberta.

Primary care clinicians grapple with ambiguity, taking in an unfiltered account of a patient’s life and priorities, so it’s no surprise that AI in decision-making will hinge significantly on its explainability.

Calcium channel blockers may be an important modifiable risk factor for glaucoma, possibly through a mechanism that is not related to intraocular pressure.

The new guidance, led by the BC Centre for Disease Control, aims to standardize take-home naloxone kits that are distributed through various sites, including pharmacies, community groups and emergency departments, to anyone who could respond to an overdose.